Noggin and Sclerostin Bone Morphogenetic Protein Antagonists Form a Mutually Inhibitory Complex
Open Access
- 1 August 2004
- journal article
- Published by Elsevier
- Vol. 279 (35) , 36293-36298
- https://doi.org/10.1074/jbc.m400521200
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Osteocyte control of bone formation via sclerostin, a novel BMP antagonistThe EMBO Journal, 2003
- Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing miceJournal of Clinical Investigation, 2003
- Skeletal Overexpression of Noggin Results in Osteopenia and Reduced Bone FormationEndocrinology, 2003
- Bone Morphogenetic Proteins, Their Antagonists, and the SkeletonEndocrine Reviews, 2003
- The BMP antagonist noggin regulates cranial suture fusionNature, 2003
- Bone Dysplasia Sclerosteosis Results from Loss of the SOST Gene Product, a Novel Cystine Knot–Containing ProteinAmerican Journal of Human Genetics, 2001
- Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)Human Molecular Genetics, 2001
- Coordinated Expression of Noggin and Bone Morphogenetic Proteins (BMPs) During Early Skeletogenesis and Induction of Noggin Expression by BMP-7Journal of Bone and Mineral Research, 1999
- Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts.Journal of Clinical Investigation, 1998
- Noggin, Cartilage Morphogenesis, and Joint Formation in the Mammalian SkeletonScience, 1998